<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04009239</url>
  </required_header>
  <id_info>
    <org_study_id>16-2754</org_study_id>
    <nct_id>NCT04009239</nct_id>
  </id_info>
  <brief_title>Time Restricted Feeding and Metabolic Rhythms</brief_title>
  <acronym>Rhythm</acronym>
  <official_title>Time Restricted Feeding and Metabolic Rhythms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current guidelines for the prevention and treatment of obesity focus on caloric restriction&#xD;
      diets and increasing physical activity, but long-term compliance to these strategies is poor.&#xD;
      The timing of meal intake relative to the light-dark and sleep-wake cycle is rarely&#xD;
      considered in metabolic health; and modifying meal timing is likely easier to implement in&#xD;
      daily life than reducing caloric intake and/or increasing physical activity. This project&#xD;
      will test whether restricting the timing of energy intake to a short-defined period during&#xD;
      wakefulness can be used to improve fuel utilization patterns and enhance circadian rhythms in&#xD;
      metabolic tissues to optimize health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Time restricted feeding (TRF; eating within &lt;10-h period followed by &gt;14-h fast) is a&#xD;
      promising meal timing paradigm that in rodent studies improves multiple health indicators.&#xD;
      When provided access to a high-fat diet ad libitum, mice rapidly gain weight. However, when&#xD;
      fed the same diet under TRF conditions (food access restricted to an 8-h window during the&#xD;
      active phase) mice appear to be protected from excessive weight gain and metabolic diseases.&#xD;
      Preliminary studies in humans are showing improvements in 24-h glucose variability, fat&#xD;
      oxidation, and blood pressure with TRF aligned to the early portion of the day compared to&#xD;
      the ad libitum feeding schedule. A major research gap is whether the timing of the feeding&#xD;
      window relative to sleep modifies metabolic responses. In a recent pilot and feasibility&#xD;
      study incorporating TRF into a weight loss intervention the researchers asked participants to&#xD;
      consume all food within a 10-h window to starting 1-h after waking for 12-weeks. The&#xD;
      researchers' design choice was based on data showing that consuming energy in the evening is&#xD;
      related to a two-fold increase in obesity risk. There also appears to be reduced weight loss&#xD;
      effectiveness in dieters who consume the main meal later in the day. Some of the participants&#xD;
      in the weight loss trial reported difficulty adhering to the early feeding schedule because&#xD;
      it does not align well with social schedule (e.g., eating dinner with the family in the&#xD;
      evening). Therefore, an important clinical question is whether late or mid-day TRF will&#xD;
      result in similar metabolic benefits compared to the early TRF paradigm that has been tested&#xD;
      in other studies.&#xD;
&#xD;
      Additional rationale for studying early vs. late timed feeding is to address a fundamental&#xD;
      question, &quot;can timed meals shift the timing of metabolic rhythms?&quot;. Peripheral circadian&#xD;
      clocks located in liver, adipose, and muscle tissue are sensitive to meal timing and control&#xD;
      daily oscillations in fuel utilization and storage. A small study of 8 men demonstrated that&#xD;
      a 5-h delay and meal timing was sufficient to delay the rhythmic expression of clock genes in&#xD;
      white adipose tissue. Therefore, the investigators will leverage the design of the present&#xD;
      study to examine the impact of meal timing on peripheral circadian rhythms in metabolism and&#xD;
      their alignment to the sleep cycle.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total fat oxidation in response to eTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Total fat oxidation will measured by whole room calorimetry. Early Time Restricted Feeding (eTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total fat oxidation in response to mTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Total fat oxidation will measured by whole room calorimetry. Mid-day Time Restricted Feeding (mTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin sensitivity in response to eTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Insulin sensitivity measured by three identical mixed meal tolerance tests administered across the day. Early Time Restricted Feeding (eTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin sensitivity in response to mTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Insulin sensitivity measured by three identical mixed meal tolerance tests administered across the day. Mid-day Time Restricted Feeding (mTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose control in response to eTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Glucose control will be measured by a continuous glucose monitor. Mid-day Time Restricted Feeding (mTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose control in response to mTRF</measure>
    <time_frame>Week 1 or Week 5</time_frame>
    <description>Glucose control will be measured by a continuous glucose monitor. Early Time Restricted Feeding (eTRF) may occur at Week 1 or Week 5 depending on randomization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in dietary fat oxidation between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Dietary fat oxidation will be measured using a stable isotope tracer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in 24h energy expenditure between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>24h energy expenditure will be measured using whole room calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in sleep between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Sleep will be measured by polysomnography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in the melatonin rhythm between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>The melatonin profile will be measured in plasma during constant routine protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in plasma metabolite rhythms between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Plasma metabolite rhythms will be measured using a constant routine protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in plasma hormone rhythms between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Plasma hormone rhythms will be measured using a constant routine protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in plasma gene expression rhythms between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Plasma gene expression rhythms will be measured using a constant routine protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in energy expenditure rhythms between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Energy expenditure rhythms will be measured by indirect calorimetry during a constant routine protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in substrate oxidation rhythms between experimental conditions</measure>
    <time_frame>Week 1 and Week 5</time_frame>
    <description>Substrate oxidation rhythms will be measured by indirect calorimetry during a constant routine protocol</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Early Time Restricted Feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consume meals for 7 days during an 8 hour window starting 1 hour after habitual wake time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mid-day Time Restricted Feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consume meals for 7 days during an 8 hour window starting 6 hours after habitual wake time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Time Restricted Feeding</intervention_name>
    <description>Consuming energy during a short interval during the day</description>
    <arm_group_label>Early Time Restricted Feeding</arm_group_label>
    <arm_group_label>Mid-day Time Restricted Feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women with overweight and class I obesity (N=12, Age=20-50 years; BMI 25-35&#xD;
             kg/m2)&#xD;
&#xD;
          -  Low physical activity level (â‰¤150 min/wk of moderate-to-vigorous activity);&#xD;
&#xD;
          -  For Females- Not currently pregnant or lactating and not pregnant within the past 6&#xD;
             months&#xD;
&#xD;
          -  Habitually consume food over a window of &gt;12 h/day;&#xD;
&#xD;
          -  Pass a medical and physical screening performed by the study physician.&#xD;
&#xD;
          -  Report a habitual, regular sleep-wake cycle for the month preceding screening that&#xD;
             involved going to bed between 2200 and 0100h and getting up between 0600 and 0900 h&#xD;
             with &gt;7 h and &lt;9.25 h in bed;&#xD;
&#xD;
          -  Agree to eat control diets at imposed times for 1 week prior to the inpatient CTRC&#xD;
             visits;&#xD;
&#xD;
          -  Agree to keep a regular sleep/wake schedule for the duration of the study&#xD;
&#xD;
          -  Possess a smart phone to install and utilize the meal timing application.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects must not be currently participating in another research study that would&#xD;
             influence their safe participation in this study. For example, subjects must not be&#xD;
             participating in a research study in which they ingest experimental medication, or&#xD;
             which involves blood samples, since both of these factors could increase risk of&#xD;
             participation;&#xD;
&#xD;
          -  Being considered unsafe to participate as determined by the study physician;&#xD;
&#xD;
          -  Taking medications affecting weight, triglycerides, energy intake/energy expenditure,&#xD;
             or sleep in the last 3 months;&#xD;
&#xD;
          -  Having abnormal blood chemistry and/or hematology as deemed significant by the study&#xD;
             physician;&#xD;
&#xD;
             o Have one or more of the following out-of-range values measured on a fasting blood&#xD;
             sample: glucose &gt; 126 mg/dl, HbA1c &gt; 6.5%, thyroid stimulating hormone &lt;0.5 or &gt;5.0&#xD;
             uU/ml. Subjects who may be anemic (hemoglobin &lt;14.5 g/dl men, &lt;12.3 g/dl women), have&#xD;
             abnormal liver function tests (alanine amino transferase &gt; 47 U/l, aspartate&#xD;
             aminotransferase, &gt; 47 U/l, alkaline phosphatase &lt;39 or &gt;117 U/l) or creatinine (&gt;1.1&#xD;
             mg/dl)&#xD;
&#xD;
          -  Significant abnormality in clinical laboratory values&#xD;
&#xD;
          -  Ever having a history of systemic, psychiatric, neurological disease, or drug and&#xD;
             alcohol abuse;&#xD;
&#xD;
          -  History of cardiovascular disease, diabetes, uncontrolled hypertension, untreated&#xD;
             thyroid, renal, hepatic diseases, dyslipidemia or any other medical condition&#xD;
             affecting weight or lipid metabolism;&#xD;
&#xD;
          -  Score &gt; 18 on Beck Depression Index (BDI) will require further assessment by the study&#xD;
             physician to determine if it is appropriate for the subject to participate in the&#xD;
             study;&#xD;
&#xD;
          -  Use of a continuous positive airway pressure (CPAP) device for the treatment of&#xD;
             obstructive sleep apnea (OSA). A score of &gt;10 on the Epworth sleepiness scale or &gt;5 on&#xD;
             the Pittsburgh Sleep Quality Index will require further assessment by the study&#xD;
             physician to determine if it is appropriate for the subject to participate in the&#xD;
             study;&#xD;
&#xD;
          -  Being positive for human immunodeficiency virus or hepatitis B or C;&#xD;
&#xD;
          -  Being a smoker or having been a smoker in the previous 6 months;&#xD;
&#xD;
          -  Abnormal eating patterns identified by registered dietician interview (dietary&#xD;
             fat&lt;15%, dietary fat&gt;45%, dietary protein &gt;30%);&#xD;
&#xD;
          -  Working night shifts;&#xD;
&#xD;
          -  Night eating syndrome (at least 25% of food intake is consumed after the evening meal&#xD;
             and/or at least two episodes of nocturnal eating per week);&#xD;
&#xD;
          -  Traveling &gt; 2 time zones 2 weeks prior to an inpatient CTRC study visit;&#xD;
&#xD;
          -  Currently participating in any formal weight loss or physical activity programs or&#xD;
             clinical trials.&#xD;
&#xD;
          -  Having a clinically significant allergy (e.g., to food stuffs such as shellfish,&#xD;
             peanuts);&#xD;
&#xD;
          -  Celiac disease or known sensitivity to gluten (the metabolic kitchen is not gluten&#xD;
             free certified and cannot accommodate this dietary restriction)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corey A Rynders, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado - Anschutz Medical Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Celia Ernstrom, BS</last_name>
    <phone>303.724.4393</phone>
    <email>rhythm@cuanschutz.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>July 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Weight loss</keyword>
  <keyword>Diet</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

